Sign in
CompletedNo phase

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

Key facts

Who runs it
Imperative Care, Inc.
Where
Atlanta, Cincinnati, Dallas, Detroit, Fort Worth, Glenview, Grand Rapids, Greenville, Huntsville, Indianapolis, Jacksonville, Los Angeles, Mount Kisco, New York, Norfolk, Plano, Royal Oak, and Tallahassee, United StatesSee the 19 sites
Trial code
Status
Completed
People taking part
110 people enrolled
Started
13 Dec 2023
Ended
29 May 2025
Type of study
Interventional
Treatments tested
  • Symphony Thrombectomy System
Record updated
10 August 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 32 criteriaShow less

Who can take part

  • CTA evidence of acute PE within ≤14 days
  • Clinical signs and symptoms consistent with acute PE
  • Systolic BP ≥90 mmHg with evidence of dilated RV with an RV/LV ratio >0.9 (based on Investigator's assessment of RV/LV ratio)
  • Stable heart rate <130 BPM prior to procedure
  • Subject is between 18 and 80 years of age
  • Subject is willing to sign an IRB-approved informed consent form
  • Subject is willing and able to comply with protocol follow-up

Who cannot take part

  • Cardiovascular or pulmonary surgery within last 7 days
  • Experienced cardiac arrest
  • Known bleeding diathesis or coagulation disorder
  • Cancer requiring active chemotherapy
  • Pulmonary hypertension with peak pulmonary artery pressure >70 mmHg by right heart catheterization
  • COVID-19 positive at hospital admission
  • International Normalized Ratio (INR) >3
  • Platelets <100,000/µL
  • Kidney dysfunction as confirmed by serum creatinine >1.8 mg/dL or GFR <45 mL/min
  • Hematocrit <28% or hemoglobin <9 g/dL
  • History of chronic severe pulmonary hypertension, and/or chronic left heart disease with left ventricular ejection fraction ≤30%
  • Thrombolytic use within 14 days of baseline CTA
  • Systolic BP <90 mmHg for 15 min or requirement of inotropic support to maintain systolic BP ≥90 mmHg any time after admission
  • Has left bundle branch block
  • Presence of intracardiac lead in the right ventricle or right atrium
  • Presence of intracardiac thrombus
  • Major trauma within the past 14 days
  • Known serious, uncontrolled sensitivity to radiographic agents
  • Contraindication to anticoagulants, i.e., heparin or alternative
  • Patient on extracorporeal membrane oxygenation (ECMO)
  • Heparin-induced thrombocytopenia (HIT)
  • Life expectancy <90 days as determined by investigator
  • Pregnant or nursing
  • Current participation in another investigational study
  • Evidence such as imaging or other that suggests the subject is not appropriate for this procedure (e.g., target vessel size is too small to accommodate 16F or 24F catheters)

Where in United States

  • Emory UniversityAtlanta, United States
  • Bon Secours Mercy Health, IncCincinnati, United States
  • Medical City Dallas HospitalDallas, United States
  • Ascension St. John HospitalDetroit, United States
  • Medical City Fort Worth HospitalFort Worth, United States
  • Endeavor HealthGlenview, United States
  • Corewell HealthGrand Rapids, United States
  • Prisma HealthGreenville, United States
  • Huntsville HospitalHuntsville, United States
  • Indiana UniversityIndianapolis, United States
  • First Coast Cardiovascular InstituteJacksonville, United States
  • Cedars-Sinai Medical CenterLos Angeles, United States
  • Northwell HealthMount Kisco, United States
  • Icahn School of Medicine at Mount SinaiNew York, United States
  • NYU Grossman School of MedicineNew York, United States
  • Sentara Norfolk General HospitalNorfolk, United States
  • The Heart Hospital Baylor PlanoPlano, United States
  • William Beaumont Hospital-Royal OakRoyal Oak, United States
  • Tallahassee Memorial HospitalTallahassee, United States

About the trial

What the trial wants to find out

Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism

The group in the trial

  • Symphony Thrombectomy systemTreatment being tested

    Mechanical thrombectomy using the Symphony Thrombectomy system for the treatment of acute pulmonary embolism.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism
Publications
Record updated
10 August 2026